Riskpilot← Back to searchSign inGet full accessRIPEVIAL ApS
APSActiveCVR 32674941Kildebakken 30Development of building projects · NACE 6812Est. 20101 employees
Revenue 2025
DKK 846K
-12% vs 2024
EBITDA margin
81.4%
-15% vs 2024
Equity ratio
73.6%
Financial strength
Net profit 2025
DKK 10,8M
+249% vs 2024
| Revenue | DKK 846K | -12% |
| EBITDA | DKK 688K | -15% |
| Net profit | DKK 10,8M | +249% |
| Total assets | DKK 45,5M | +10% |
| Equity | DKK 33,4M | +15% |
| Employees | 1 | — |
Legal name
RIPEVIAL ApS
CVR number
32674941
Legal form
Anpartsselskab
NACE code
6812 · Development of building projects
Founded
18. januar 2010
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at eje aktier og andre værdipapirer.
Address
Kildebakken 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -7 | -7 | -7 | 156 | -8 | -10 | -30 | -30 | -201 | 549 | 756 | 698 | 959 | 846 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -160 | -203 | -197 | -152 | -157 |
| EBITDA | -7 | -7 | -7 | 156 | -8 | -10 | -30 | -30 | -201 | 281 | 552 | 500 | 807 | 688 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -57 | -93 | -638 | -627 | -610 | -610 |
| EBIT | -7 | -7 | -7 | 156 | -8 | -10 | -30 | -30 | -258 | 187 | -86 | -127 | 197 | 78 |
| Net financials | 656 | 3.032 | 4.933 | 6.734 | 6.146 | 10.941 | 5.264 | 5.607 | 4.099 | 6.460 | 5.000 | 1.585 | 2.987 | 10.634 |
| Profit before tax | 649 | 3.025 | 4.925 | 6.890 | 6.138 | 10.931 | 5.234 | 5.577 | 3.841 | 6.648 | 4.915 | 1.458 | 3.184 | 10.712 |
| Tax | -90 | 116 | 305 | 113 | 78 | -29 | -159 | 108 | -8 | 661 | 175 | -54 | 97 | -73 |
| Net profit | 739 | 2.909 | 4.620 | 6.777 | 6.060 | 10.960 | 5.393 | 5.469 | 3.849 | 5.986 | 4.740 | 1.512 | 3.087 | 10.785 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11.537 | 13.310 | 16.449 | 19.907 | 20.685 | 26.977 | 32.183 | 33.508 | 38.724 | 51.511 | 52.156 | 44.599 | 41.423 | 45.456 |
| Equity | 11.395 | 13.304 | 16.174 | 19.451 | 20.011 | 26.971 | 29.364 | 31.331 | 31.930 | 34.916 | 34.906 | 31.418 | 29.153 | 33.438 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.655 | 8.718 | 8.237 | 8.322 | 7.930 |
| Short-term debt | 142 | 7 | 275 | 456 | 675 | 7 | 2.819 | 2.177 | 6.794 | 6.939 | 8.532 | 4.944 | 3.948 | 4.088 |
| Total debt | 142 | 7 | 275 | 456 | 675 | 7 | 2.819 | 2.177 | 6.794 | 16.594 | 17.250 | 13.181 | 12.270 | 12.018 |
EBITDA margin
81.4%
This company
15.8%
Market median
+415% vs market
20122025
Equity ratio
73.6%
This company
38.2%
Market median
+93% vs market
20122025
Return on equity
32.3%
This company
18.4%
Market median
+76% vs market
20122025
Net profit margin
1275.1%
This company
8.1%
Market median
+15642% vs market
20122025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20122025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RIPEVIAL ApS 
EMR, MURER & ENTREPRENØR A/SBoard members of RIPEVIAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|